000 01230 a2200313 4500
005 20250516185235.0
264 0 _c20141009
008 201410s 0 0 eng d
022 _a1759-4804
024 7 _a10.1038/nrrheum.2013.203
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIsenberg, David A
245 0 0 _aSystemic lupus erythematosus in 2013. Taking a closer look at biologic therapy for SLE.
_h[electronic resource]
260 _bNature reviews. Rheumatology
_cFeb 2014
300 _a71-2 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntibodies, Monoclonal, Humanized
_xtherapeutic use
650 0 4 _aAntibodies, Monoclonal, Murine-Derived
_xtherapeutic use
650 0 4 _aBiological Therapy
650 0 4 _aHumans
650 0 4 _aLupus Erythematosus, Systemic
_xdrug therapy
650 0 4 _aMycophenolic Acid
_xanalogs & derivatives
650 0 4 _aRituximab
650 0 4 _aTranslational Research, Biomedical
650 0 4 _aTreatment Outcome
700 1 _aRahman, Anisur
773 0 _tNature reviews. Rheumatology
_gvol. 10
_gno. 2
_gp. 71-2
856 4 0 _uhttps://doi.org/10.1038/nrrheum.2013.203
_zAvailable from publisher's website
999 _c23371889
_d23371889